Global Regulatory Lifecycle Management Case Study

Case Study Overview

Managing pharmaceutical products across multiple markets requires ongoing coordination of regulatory submissions, post-approval changes, product documentation and local requirements. For hormone-based pharmaceutical products, these activities must be managed throughout the product lifecycle to support continued compliance and market availability.

DDReg supported global regulatory lifecycle management across more than 60 countries, covering product registrations, marketing authorisation transfers, API supplier changes and related regulatory activities. The engagement focused on maintaining regulatory compliance, supporting market expansion and coordinating stakeholders involved in the product lifecycle.

Key areas of support:

Global product registration and market access
Post-approval regulatory lifecycle management
API supplier changes and qualification
Marketing authorisation transfers
Labelling, artwork and packaging compliance
Regulatory coordination with CMOs and other partners

The Challenge: Managing Regulatory Requirements Across Global Markets

Managing these activities across multiple jurisdictions requires each regulatory change to be assessed against the requirements applicable to the individual market. A change that requires a submission or approval in one country may follow a different procedure or timeline in another. Coordinating these differences is important when managing supplier changes, marketing authorisation transfers and new product registrations across an international portfolio.

For the hormone-based products in this engagement, the key priorities were to:

Maintain regulatory compliance: Address applicable market requirements and manage lifecycle activities across 60+ countries.
Support uninterrupted market availability: Coordinate regulatory activities and approvals in line with the need to maintain product supply.
Manage product and supply-chain changes: Support API supplier changes and marketing authorisation transfers while coordinating the relevant regulatory stakeholders.
Enable market expansion: Support product registrations and regulatory activities required for entry into additional markets.

DDReg’s Approach to Global Regulatory Lifecycle Management

Coordinating Regulatory Activities Across Markets
DDReg supported regulatory lifecycle activities across more than 60 countries, helping coordinate product registrations, post-approval activities and market-specific regulatory requirements. Managing these activities within a coordinated framework helped maintain visibility across the product portfolio while recognising that submission procedures, documentation requirements and approval processes can vary between jurisdictions.
Managing API Supplier Changes and Regulatory Transfer
Changes to an active pharmaceutical ingredient (API) supplier may affect approved product documentation and require regulatory assessment in the relevant markets. Depending on the nature of the change, applicable requirements may involve supporting documentation, ectd regulatory submissions or approval before implementation. Marketing authorisation transfers can also require market-specific procedures and documentation.
DDReg supported API sourcing, supplier qualification, change management and marketing authorisation transfers as part of the broader lifecycle programme. These activities required coordination between regulatory stakeholders and the relevant supply-chain partners to support alignment with applicable requirements.
Supporting Global Registrations and Market Expansion
Product registration in additional markets requires the applicable national or regional requirements to be identified and addressed. These may include submission documentation, product information and local procedural requirements.
DDReg supported global product registration and market access activities as part of the wider lifecycle management programme. Coordinating registration activities with existing product obligations helped align market expansion efforts with the regulatory requirements applicable to each jurisdiction.
Managing Product Information and Stakeholder Coordination
Labelling, artwork and packaging must reflect the requirements applicable to each market. Changes to product information therefore need to be coordinated with relevant regulatory documentation and implementation activities.
DDReg’s scope also included coordination with contract manufacturing organisations (CMOs), partners and regulatory stakeholders. Bringing these activities together supported communication between the teams involved in regulatory compliance, product documentation and supply-chain management across the international portfolio.

Outcomes and Business Impact

The engagement supported coordinated regulatory lifecycle management for hormone-based pharmaceutical products across more than 60 countries.

Key outcomes included:

Regulatory oversight: Supported the management of regulatory obligations across multiple markets.
Market continuity: Supported regulatory activities associated with maintaining product availability.
Market expansion: Supported product registrations and market access activities in additional markets.
Change management: Supported API supplier changes and marketing authorisation transfers.
Regulatory risk management: Helped coordinate lifecycle activities with consideration of applicable market requirements.
Stakeholder coordination: Supported collaboration among partners, CMOs and regulatory stakeholders.

Together, these activities addressed regulatory responsibilities extending beyond initial registration and supported ongoing management of the international product portfolio.

Key Learnings

This engagement highlights three important considerations for global pharmaceutical lifecycle management:

Regulatory requirements must be managed market by market. A global product portfolio still requires attention to the requirements and procedures applicable in individual jurisdictions.
Changes need regulatory assessment alongside operational planning. Supplier changes and marketing authorisation transfers should be considered within the relevant market requirements and the wider product lifecycle.
Coordination is essential to effective implementation. Regulatory teams, partners and manufacturing organisations need to work together so that regulatory responsibilities remain aligned with product and supply-chain activities.

These principles are consistent with the lifecycle management approach described in ICH Q12, which provides a framework for managing post-approval changes to the chemistry, manufacturing and controls (CMC) aspects of pharmaceutical products. Its relevance is to lifecycle management and post-approval change management; it does not establish a separate regulatory pathway for hormone-based products.

Why Global Regulatory Lifecycle Management Matters

Global regulatory lifecycle management helps pharmaceutical companies coordinate product registrations, post-approval changes and ongoing regulatory obligations across markets. For international portfolios, a structured approach helps teams account for differences in local requirements while aligning regulatory activities with product documentation and supply-chain changes.

Effective regulatory lifecycle management in pharma depends on coordination between regulatory, quality and manufacturing teams. Pharmaceutical product lifecycle management may also be supported by regulatory lifecycle management software, which helps organise regulatory information and track activities. However, software does not replace market-specific regulatory assessment or the expertise required to manage changes appropriately.

How DDReg Supports Global Regulatory Lifecycle Management

DDReg supports pharmaceutical companies with regulatory strategy services and regulatory lifecycle management tool, global product registration and market access, labelling and packaging compliance, API sourcing and change management, and regulatory coordination with CMOs and other partners.

By connecting these activities within a coordinated approach, DDReg helps companies manage regulatory obligations across markets and support product compliance throughout the lifecycle.

Conclusion

Managing hormone-based pharmaceutical products across more than 60 countries required coordination of product registrations, API supplier changes, marketing authorisation transfers and ongoing regulatory obligations. DDReg supported these activities through a coordinated lifecycle management approach, helping address market-specific requirements and support the management of the international product portfolio.